- Revenues for the 2023 financial year at EUR 9.2 million after pandemic-driven record years (2022: EUR 11.3 million)
- Important progress for Carragelose with new distribution partners and new products as well as Marinosolv assets with improved stability for lead products
- Outlook 2024 and beyond: Primary goal to achieve operating profitability through commercialization of Carragelose and Marinosolv assets
The full press release is available as download here: